Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for OCGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 339.04M
March 31, 2026 338.32M
December 31, 2025 312.38M
September 30, 2025 312.32M
June 30, 2025 292.19M
March 31, 2025 292.03M
December 31, 2024 291.37M
September 30, 2024 290.26M
June 30, 2024 257.42M
March 31, 2024 257.33M
December 31, 2023 256.57M
September 30, 2023 256.50M
June 30, 2023 256.49M
March 31, 2023 226.43M
December 31, 2022 221.60M
September 30, 2022 216.69M
June 30, 2022 216.15M
March 31, 2022 215.63M
December 31, 2021 199.38M
September 30, 2021 198.93M
June 30, 2021 198.70M
March 31, 2021 188.16M
December 31, 2020 184.01M
September 30, 2020 162.03M
June 30, 2020 135.01M
Date Value
March 31, 2020 52.63M
December 31, 2019 52.63M
September 30, 2019 10.01M
June 30, 2019 1.577M
March 31, 2019 1.577M
December 31, 2018 4.960M
September 30, 2018 0.5834M
June 30, 2018 0.4799M
March 31, 2018 0.4781M
December 31, 2017 0.4095M
September 30, 2017 0.3799M
June 30, 2017 0.3713M
March 31, 2017 0.3695M
December 31, 2016 0.3441M
September 30, 2016 0.2645M
June 30, 2016 0.2212M
March 31, 2016 0.2212M
December 31, 2015 0.2212M
September 30, 2015 0.2212M
June 30, 2015 0.2206M
March 31, 2015 0.2203M
December 31, 2014 0.2126M
September 30, 2014 0.2274M
June 30, 2014 0.1129M
March 31, 2014 0.107M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 172.13M
Biogen, Inc. 147.70M
Gilead Sciences, Inc. 1.241B
MannKind Corp. 309.91M
Vertex Pharmaceuticals, Inc. 253.35M